NCT03592121View on ClinicalTrials.gov

Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

July 9, 2018

Primary Completion Date

October 12, 2019

Study Completion Date

October 12, 2019

Conditions
Sexual DysfunctionSexual Arousal DisorderSexual Dysfunction, PhysiologicalBreast CancerNipple DisorderNeuropathyCancer of Breast
Interventions
DRUG

AB-101

Apply approximately 1 hour prior to sexual activity

DRUG

Placebo

Apply approximately 1 hour prior to sexual activity

Trial Locations (1)

92663

Southern CA Center for Sexual Health and Survivorship Medicine, Newport Beach

Sponsors
All Listed Sponsors
lead

Applied Biology, Inc.

INDUSTRY